In July of 2018, Angiex launched an experiment to the International Space Station (ISS) U.S. National Laboratory to test our highly selective cancer therapy that targets both tumor cells and the endothelial cells of tumor blood vessels. Our project was supported by a MassChallenge “Technology in Space Prize,” awarded by the ISS National Laboratory and Boeing.
Created: 2020-05-30
Updated: 2022-02-26
Service
- Classification
- Miscellaneous
- Category
- Microgravity Science
- Fields
- Astrobiotech
- Status
- 3) Development
- First launch
- ?